UK markets closed

BerGenBio ASA (BGBIOO.XC)

Cboe UK - Cboe UK Real-time price. Currency in NOK
Add to watchlist
0.26830.0000 (0.00%)
At close: 02:00PM BST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
521
354
389
774
601
-
Operating expenses
Research development
82,177
107,786
202,403
205,820
185,234
-
Selling general and administrative
-
-
-
12,744
21,792
21,225
Total operating expenses
159,680
192,173
306,024
315,236
261,693
-
Operating income or loss
-159,159
-191,819
-305,635
-314,462
-261,092
-
Interest expense
-1,402
578
321
53
32
-
Income before tax
-154,520
-190,401
-302,122
-309,364
-257,029
-
Income tax expense
0
0
0
0
0
-
Income from continuing operations
-154,520
-190,401
-302,122
-309,364
-257,029
-
Net income
-154,520
-190,401
-302,122
-309,364
-257,029
-
Net income available to common shareholders
-154,520
-190,401
-302,122
-309,364
-257,029
-
Basic EPS
-0.55
-13.00
-341.00
-303.91
-296.14
-
Diluted EPS
-0.55
-13.00
-341.00
-303.91
-296.14
-
Basic average shares
804,599
14,313
886.364
1,019
867.758
-
Diluted average shares
804,599
14,313
886.364
1,019
867.758
-